Table 2:
Demographics and clinical diagnosis for brain tissues.
| Asymptomatic Control | Symptomatic | ||
|---|---|---|---|
| non-carrier (N=15) |
non-carrier (N=4) |
GRN (N=10) |
|
| Age at Death | |||
| Mean (SD) | 68.5 (5.85) | 69.3 (6.50) | 67.3 (6.65) |
| Median [Min, Max] | 70.0 [58.0, 76.0] | 68.0 [63.0, 78.0] | 67.0 [56.0, 78.0] |
| Sex | |||
| Female | 6 (40.0%) | 2 (50.0%) | 8 (80.0%) |
| Male | 9 (60.0%) | 2 (50.0%) | 2 (20.0%) |
| Clinical Diagnosis | |||
| Clinical Normal | 15 (100%) | 0 (0%) | 0 (0%) |
| Behavioral Variant Frontotemporal Dementia | 0 (0%) | 1 (25.0%) | 6 (60.0%) |
| Mixed Frontotemporal Dementia | 0 (0%) | 0 (0%) | 1 (10.0%) |
| Primary Progressive Aphasia, Unspecified | 0 (0%) | 0 (0%) | 1 (10.0%) |
| Corticobasal Syndrome | 0 (0%) | 2 (50.0%) | 1 (10.0%) |
| Progressive Non-Fluent Aphasia | 0 (0%) | 1 (25.0%) | 0 (0%) |
| Corticobasal syndrome/Progressive Non-Fluent Aphasia | 0 (0%) | 0 (0%) | 1 (10.0%) |